Polymeric nanospheres modified with YIGSR peptide for tumor targeting

Drug Delivery

Volumn 17, Issue 7, 2010, Pages 541-551

  Dubey, Praveen K ^a   Singodia, Deepak ^b   Vyas, S P ^c  

^a Strides Arcolab Limited   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c DR H S GOUR UNIVERSITY   (India)

Author keywords

Albumin nanospheres; Angiogenesis; Metastasis; Tumor targeting; YIGSR peptide

Indexed keywords

FLUOROURACIL; LAMININ RECEPTOR; MACROGOL; NANOSPHERE; POLYMER; TYROSYLISOLEUCYLGLYCYLSERYLARGININE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CANCER MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; MOUSE; NEOPLASM; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; UMBILICAL VEIN;

ANIMALS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FLUOROURACIL; HUMANS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NANOSPHERES; OLIGOPEPTIDES; PEPTIDES; POLYMERS; UMBILICAL CORD;

EID: 77956155952     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.490249     Document Type: Article

References (43)

1. Albertsson, P., Lennernas, B., Norrby, K. (2006). On metronomic chemotherapy: modulation of angiogenesis mediated by VEGF-A. Acta Oncol. 45:144-155
2. Andukuri, A., Minor, W.P., Kushwaha, M., Anderson, J.M., Jun, H.W. (2009). Efect of endothelium mimicking self-assembled nano-matrices on cell adhesion and spreading of human endothelial cells and smooth muscle cells. Nanomed Biol Med. 6:289-297.
3. Barcons, L.A.L., Polo, D., Reig, F., Fabra, A. (2003). Pentapeptide YIGSR-mediated HT-1080 fbrosarcoma cells targeting of adri-amycin encapsulated in sterically stabilized liposomes. Inc J Biomed Mater Res. 69:155-163
4. Boehm, T., Folkman, J., Browder, T., O'Reilly, M.S. (1997). Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 390:404-407
5. Brannon-Peppas, L., Blanchette, J.O. (2004). Nanosphere and targeted systems for cancer therapy. Adv Drug Deliv Rev. 56:1649-1659
6. Brooks, P.C., Clark, R.A., Cheresh, D.A. (1994). Requirement of vascular integrin avb3 for angiogenesis. Science. 264:569-571
7. Browder, T., Butterfeld, C.E., Kraling, B.M., Shi, B., Marshall, B., O'Reilly, M.S. (2000). Antiangiogenic scheduling of chemotherapy improves efcacy against experimental drug-resistant cancer. Cancer Res. 60:1878-1886
8. Colorado, P.C., Torre, A., Kamphaus, G., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E.D., Herman, S., Sarkar, P.K., Ericksen, M.B., Dhanabal, M., Simons, M., Post, M., Kufe, D.W., Weichselbaum, R.R., Sukhatme, V.P., Kalluri, R. (2000). Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60:2520-2526
9. Compagnon, P., Tiberville, L., Moore, N., Tuillez, C., Lacroix, C. (1996). Simple high-performance liquid chromatographic method for the quantitation of 5-fuorouracil in human plasma. J Chromatogr B. 677:380-383
10. Dixelius, J., Jakobsson, L., Genersch, E., Bohman, S., Ekblom, P., Claesson-Welsh, L. (2004). Laminin-1 promotes angiogenesis in synergy with fbroblast growth factor by distinct regulation of the gene and protein expression profle in endothelial cells. J Biol Chem. 279:23766-23772
11. Drevs, J., Fakler, J., Eisele, S., Medinger, M., Bing, G., Esser, N. (2004). Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy. Anticancer Res. 24:1759-1763
12. Farina, A.R., Tacconelli, A., Cappabianca, L., Desantis, G., Gulino, A., Mackay, A.R. (2003). Tioredoxin inhibits microvascular endothe-lial capillary tubule formation. Exp Cell Res. 291:474-483
13. Fidler, I.J. (1984). The Ernst W. Bertner memorial award lecture: the evolution of biological heterogeneity in metastatic neoplasms. In: Nicolson, G.I., Milas, I., eds. Cancer invasion and metastasis. Biologic and therapeutic aspects. New York: Rason Press, 5-9.
14. Fischer, D., Bieber, T., Brusselbach, S., Elsasser, H., Kissel, T. (2001). Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efciency. Int J Pharm. 225:97-111.
15. Forssen, E., Willis, W. (1998). Ligand targeted liposomes. Adv Drug Deliv Rev. 29:249-271
16. Fridman, R., Giaccone, G., Kanemoto, T., Martin, G.R., Gazdan, A.F. Mulshine, J.L. (1990). Reconstituted basement membrane matrigel. and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA. 87:6698-6702
17. Givant-Horwitz, V., Davidson, B., Reich, R. (2004). Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res. 64:3572-3579
18. Givant-Horwitz, V., Davidson, B., Reich, R. (2005). Laminin-induced signaling in tumor cells. Cancer Lett. 223:1-10.
19. Gladson, C.L., Cheresh, D.A. (1991). Glioblstoma expression of vit-ronectin and the avb3 integrin. J Clin Invest. 88:1924-1932
20. Habeeb, A.F. (1966). Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 14:328-336
21. Ito, Y., Iwamoto, Y., Tanaka, K., Okuyama, K., Sugioka, Y. (1996). A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int J Cancer. 67:148-152
22. Iwamoto, Y., Fujita, Y., Sugioka, Y. (1992). YIGSR, a synthetic laminin peptide, inhibits the enhancement by cyclophosphamide of experimental lung metastasis of human fbrosarcoma cells. Clin Exp Metastasis. 10:183-189
23. Kapoor, D.N., Manvi, F.V., Doijad, R.C., Dhawan, S. (2008). Prednisolone-loaded albumin nanospheres: in vitro and in vivo evaluation studies. PDA J Pharm Sci Technol. 62:111-124
24. Kleinman, H.K., McGarvey, M.L., Hassel, J.R., Star, V.L., Cannon, F.B., Laurie, G.W., Martin, G.R. (1986). Basement membrane complexes with biological activities. Biochemistry. 25:312-318
25. Li, D., Chen, J., Gao, Z., Li, X., Yan, X., Xiong, Y., Wang, S. (2009). 67-kDa laminin receptor in human bile duct carcinoma. Eur Surg Res. 42:168-173
26. Li, J.M., Chen, W., Wang, H., Jin, C., Yu, X.J., Lu, W.Y., Cui, L., Fu, D.L., Ni, Q.X., Hou, H.M. (2009). Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro. Acta Pharmacol Sin. 30:1337-1343
27. Lu, B., Xiong, S.B., Yang, H., Yin, X.D., Zhao, R.B. (2006). Mitoxantrone-loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases. II: Tissue distribution and pharmacodynamics. Int J Pharm. 307:175-181
28. Miron, T., Wilchek, M. (1993). A simplifed method for the preparation of succinimidyl carbonate polyethylene glycol for coupling to proteins. Bioconjug Chem. 4:568-569
29. Mishra, V., Mahor, S., Rawat, A., Gupta, P.N., Dubey, P., Khatri, K., Vyas, S.P. (2006). Targeted brain delivery of AZT via transfer-rin anchored pegylated albumin nanospheres. J Drug Target. 14:45-53.
30. Nakagawa, Y., Takama, K., Deda, H., Machida, Y., Nagai, T. (1987). Preparation of bovine serum albumin nanospheres as targeting carrier. Drug Design Del. 2:99-107.
31. Oroszlan, M., Herczenik, E., Rugonfalvi-Kiss, S., Roos, A., Nauta, A.J., Daha, M.R., Gombos, I., Karadi, I., Romics, L., Prohaszka, Z., Fust, G., Cervenak, L. (2006). Proinfammatory changes in human umbilical cord vein endothelial cells can be induced neither by native nor by modifed CRP. Int Immunol. 18:871-878
32. Sakamoto, N., Iwahana, M., Tanaka, N.G., Osada, Y. (1991). Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide DPGYIGSR-NH2. Cancer Res. 51:903-906
33. Santhi, K., Dhanaraj, S.A., Joseph, V., Ponnusankar, S., Suresh, B. (2002). A study on the preparation and anti-tumor efcacy of bovine serum albumin nanospheres containing 5-fuorouracil. Drug Dev Ind Pharm. 28:1171-1179
34. Selleri, C., Ragno, P., Ricci, P., Visconte, V., Scarpato, N., Carriero, M.V., Rotoli, B., Rossi, G., Montuori, N. (2006). The metastasis-associated 67-kDa laminin receptor is involved in G-CSF-induced hematopoietic stem cell mobilization. Blood. 108:2476-2484
35. Singh, B., Rawlings, N., Kaur, A. (2001). Expression of integrin avb3 in pig, dog and cattle. Histol Histopathol. 16:1037-1046
36. Streit, M., Riccardi, L., Velasco, P., Brown, L.F., Hawighorst, T., Bornstein, P., Detmar, M. (1999). Trombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc Natl Acad Sci USA. 96:14888-14893
37. Tang, D.G., Onoda, J.M., Steinert, B.W., Grossi, I.M., Nelson, K.K., Umbarger, L., Diglio, C.A., Taylor, J.D., Honn, K.V. (1993). Phenotypic properties of cultured tumor cells: integrin alpha IIb beta 3 expression, tumor-cell-induced platelet aggregation, and tumor-cell adhesion to endothelium as important parameters of experimental metastasis. Int J Cancer. 54:338-347
38. Tanjore, H., Kalluri, R. (2006). The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol. 168:715-717
39. Tomlinson, E., Burger, J.J. (1995). Methods in enzymology. In: Widder, K., Green, R., eds. Drug and Enzyme Targeting. London: Academic Press, 112:27-43.
40. Tomlinson, E., Burger, J.J. (1985). Incorporation of water-soluble drugs in albumin. In: Widder, K., Green, R., eds. Methods in enzymol-ogy: drug and enzyme targeting. 112. London: Academic Press, 27-43.
41. Tritton, T.R., Yee, G. (1982). The anticancer agent adriamycin can be actively cytotoxic without entering the cells. Science. 217:248-250
42. Yam, H.F., Chew, E.C., Chen, H.B., Wu, S., Cheng-Chew, S.B., Yang, L., Wang, S.W., Liew, C.T., Wu, B.Q. (1997). The 67 kD laminin receptor in high and low metastasis melanoma cell lines. Oncol Rep. 4:115-118
43. Yamamura, K., Kibbey, M.C., Jun, S.H., Kleinman, H.K. (1993). Efect of matrigel and laminin peptide YIGSR on tumor growth and metastasis. Semin Cancer Biol. 4:259-265